Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension, antihypertensive therapy, and erectile dysfunction.

Athanasios G Papatsoris1, Panagiotis G Korantzopoulos

  • 12nd Department of Urology, School of Medicine, University of Athens, Sismanogleio' Hospital, Athens, Greece.

Angiology
|January 31, 2006
PubMed
Summary

Erectile dysfunction is common in hypertensive men due to shared risk factors. Effective management involves individualized therapy and medications like PDE5 inhibitors, which are safe and effective for erectile dysfunction in these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity, anti-obesity medications, and atrial fibrillation: Recent advances.

Kardiologia polska·2026
Same author

Ureteral stent related symptoms: A comparative study.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2024
Same author

Ureteral stents: A brief narrative review of the different polymeric types, their characteristics, and their connection to stent-related symptoms.

Urology annals·2023
Same author

Ureteral Stent-Related Symptoms and Pharmacotherapy: A Brief Narrative Review.

Journal of clinical pharmacology·2023
Same author

Perspectives on the urological care in Parkinson's disease patients.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2022
Same author

The Impact of COVID-19 Disease on Urology Practice.

Surgery journal (New York, N.Y.)·2021

Area of Science:

  • Cardiovascular Medicine
  • Urology

Background:

  • Erectile dysfunction (ED) is prevalent in men with hypertension.
  • Shared pathways like atherosclerosis and endothelial dysfunction link ED and hypertension.
  • Cardiovascular risk factors contribute to both conditions.

Purpose of the Study:

  • To review the relationship between hypertension and erectile dysfunction.
  • To discuss the impact of antihypertensive medications on erectile function.
  • To highlight effective treatment options for ED in hypertensive patients.

Main Methods:

  • Literature review of studies on hypertension, erectile dysfunction, and cardiovascular risk factors.
  • Analysis of the effects of various antihypertensive medications on erectile function.
  • Evaluation of phosphodiesterase-5 inhibitors and apomorphine for ED treatment in hypertensive individuals.

Related Experiment Videos

Main Results:

  • Hypertension and erectile dysfunction share common pathophysiological mechanisms.
  • Some antihypertensive drugs negatively impact erectile function, while others are neutral or beneficial.
  • Phosphodiesterase-5 inhibitors and apomorphine demonstrate high efficacy and safety in hypertensive patients with ED.

Conclusions:

  • Clinical evaluation and personalized antihypertensive therapy are crucial for managing hypertensive patients with ED.
  • Phosphodiesterase-5 inhibitors and apomorphine offer effective and safe treatment options for erectile dysfunction in hypertensive men, regardless of their antihypertensive regimen.